FDAFDA · Food and drugs·Recall number D-1302-2022
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.
Published August 10, 2022 · Recall initiated: July 21, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: below specification limits for dissolution.
What to do
Voluntary: Firm initiated
Recall details
- Brand
- MATZIM LA
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot 1411593A, Exp 09/22
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.